Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-22-000310
Filing Date
2022-02-09
Accepted
2022-02-09 17:03:33
Documents
1
Group Members
JEFF EASTONLIND GLOBAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G/A 67370
  Complete submission text file 0000929638-22-000310.txt   68903
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Subject) CIK: 0001711786 (see all company filings)

EIN.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91443 | Film No.: 22608064
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022
Business Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022 646-395-3931
Lind Global Macro Fund LP (Filed by) CIK: 0001773156 (see all company filings)

EIN.: 830854952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A